Andrew Potter is a graduate of Carleton University (Ottawa) and the University of Otago (Dunedin, New Zealand) and has worked at the Vaccine and Infectious Disease Organization, University of Saskatchewan, for the past 24 years serving as a Research Scientist, Associate Director (Research), and more recently, Director. He currently holds an NSERC Senior Industrial Research Chair in the area of vaccine development for zoonotic disease. His primary research interests are in the areas of the pathogenesis of bacterial respiratory diseases and the development of vaccines for zoonotic diseases. He has mentored more than 48 graduate students and postdoctoral fellows. He is also the Director of the Pan-Provincial Vaccine Enterprise (PREVENT), a recently established national center of excellence in commercialization and research funded by the Canadian National Centres of Excellence Program. The goal of PREVENT is to catalyze the development of vaccines for diseases which are of public health priority. He has served on a number of public and private sector committees and boards, and has been an instrumental in transferring VIDO technology from the laboratory to the private sector. He holds over 50 patents dealing with prevention of infectious diseases of animals and has published over 130 peer-reviewed papers and has made 256 conference presentations. He is a key participant in a number of large-scale international networks, including those funded by Genome Canada and the Bill and Melinda Gates Foundation Grand Challenges in Global Health.
Biography Updated on 18 April 2009